2.2200
-0.0500
(-2.20%)
At close: January 10 at 4:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
50,375.0000
45,785.0000
57,149.0000
106,559.0000
78,163.0000
Cost of Revenue
40,914.0000
33,859.0000
44,779.0000
91,319.0000
64,176.0000
Gross Profit
9,461.0000
11,926.0000
12,370.0000
15,240.0000
13,987.0000
Operating Expense
22,259.0000
16,272.0000
15,914.0000
24,323.0000
20,759.0000
Operating Income
-12,798.0000
-4,346.0000
-3,544.0000
-9,083.0000
-6,772.0000
Net Non Operating Interest Income Expense
1,040.0000
973.0000
-564.0000
-905.0000
-1,292.0000
Other Income Expense
4,716.0000
852.0000
-1,336.0000
1,117.0000
2,908.0000
Pretax Income
-7,042.0000
-2,521.0000
-5,444.0000
-8,871.0000
-5,156.0000
Tax Provision
-869.0000
-614.0000
383.0000
60.0000
129.0000
Net Income Common Stockholders
-8,231.0000
23,216.0000
-7,168.0000
-4,889.0000
-8,373.0000
Diluted NI Available to Com Stockholders
-8,231.0000
23,216.0000
-7,168.0000
-4,889.0000
-8,373.0000
Basic EPS
-2.64
7.40
-2.45
-4.80
-11.40
Diluted EPS
-2.71
7.35
-2.45
-4.80
-11.40
Basic Average Shares
3,153.8500
3,127.6000
2,950.2000
1,017.0000
731.8000
Diluted Average Shares
3,181.2500
3,155.0000
2,965.8000
1,017.0000
731.8000
Total Operating Income as Reported
-8,877.0000
--
-3,105.0000
-11,595.0000
-7,208.0000
Total Expenses
63,173.0000
50,131.0000
60,693.0000
115,642.0000
84,935.0000
Net Income from Continuing & Discontinued Operation
-6,253.0000
25,132.0000
-5,252.0000
-2,983.0000
-6,457.0000
Normalized Income
-6,173.0000
-1,907.0000
-5,827.0000
-10,147.9100
-6,769.8200
Interest Expense
837.0000
--
975.0000
905.0000
1,292.0000
Net Interest Income
1,040.0000
973.0000
-564.0000
-905.0000
-1,292.0000
EBIT
-12,798.0000
-4,346.0000
-3,544.0000
-7,966.0000
-3,864.0000
EBITDA
-9,673.0000
-1,687.0000
-9.0000
-4,487.0000
5,553.0000
Reconciled Cost of Revenue
39,989.0000
32,934.0000
42,963.0000
89,568.0000
56,883.0000
Reconciled Depreciation
3,125.0000
2,659.0000
3,535.0000
3,479.0000
9,417.0000
Net Income from Continuing Operation Net Minority Interest
-6,173.0000
-1,907.0000
-5,827.0000
-8,931.0000
-5,285.0000
Total Unusual Items Excluding Goodwill
820.0000
--
--
1,667.0000
2,034.0000
Total Unusual Items
820.0000
--
--
1,667.0000
2,034.0000
Normalized EBITDA
-9,673.0000
-1,687.0000
-9.0000
-6,154.0000
3,519.0000
Tax Rate for Calcs
0.0001
0.0002
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
--
--
--
450.0900
549.1800
12/31/2020 - 6/10/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ATLN Atlantic International Corp.
5.48
-8.60%
AWH Aspira Women's Health Inc.
0.6308
-9.89%
NDRA ENDRA Life Sciences Inc.
5.98
+1.53%
ENZ Enzo Biochem, Inc.
0.6800
-3.72%
XGN Exagen Inc.
3.1700
-3.65%
BDSX Biodesix, Inc.
1.2700
-14.19%
PRPO Precipio, Inc.
6.13
-2.63%
ISPC iSpecimen Inc.
2.6800
-6.62%
APDN Applied DNA Sciences, Inc.
0.1977
+0.20%
PRPH ProPhase Labs, Inc.
0.6490
+10.19%